Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] includes 2 drugs with a combined 3,217 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
3,217
Combined Reports
All Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| ALGLUCOSIDASE ALFA | Lumizyme | 3,149 | 526 | 823 | 16.7% |
| AVALGLUCOSIDASE ALFA | Nexviazyme | 68 | 6 | 19 | 8.8% |
Common Side Effects in Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Pyrexia | 272 | 45 |
| Dyspnoea | 219 | 30 |
| Off label use | 210 | 17 |
| Inappropriate schedule of product administration | 190 | 10 |
| Pneumonia | 185 | 78 |
| Malaise | 130 | 7 |
| Respiratory failure | 128 | 93 |
| Fatigue | 122 | 5 |
| Death | 120 | 120 |
| Disease progression | 111 | 61 |